Contineum Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
CTNM chart
What traders are saying about $CTNM
Latest postsContineum Therapeutics, Inc. news
- Qureight’s Fibrosis Imaging Biomarker Selected by Contineum...
Quantisnow ·
- Qureight’s Fibrosis Imaging Biomarker Selected by Contineum Therapeutics as a Secondary Endpoint in Phase 2 PROPEL-IPF Clinical Trial
Yahoo Finance ·
- Contineum Therapeutics Inc. (CTNM) Stock Price | Live Quotes & Charts | NASDAQ
www.timothysykes.com ·
- Johnson & Johnson reports a passive stake in Contineum Therapeutics (CTNM).
Stock Titan ·
- Contineum Therapeutics, Inc. Stock 12‑Month Price Target Cut to $21.43, Implies 121% Upside
TradingView ·
- Officer Daniel Lorrain proposes selling 4,170 Contineum Therapeutics (CTNM) shares.
Stock Titan ·
- Stifel cuts Contineum Therapeutics stock price target on valuation
Investing.com ·
- What Is Behind Contineum Therapeutics (NASDAQ:CTNM) Running PROPEL-IPF in 25 Countries?
kalkine.ca ·
- RBC Capital Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Maintains Target Price $21
Moomoo ·
- Form 8K Contineum Therapeutics Inc For: 3 November By Investing.com
Investing.com Nigeria ·
- Contineum Therapeutics Reports $18.7 Million Third-Quarter Net Loss
TradingView ·
- Contineum Therapeutics Reports Third-Quarter 2026 Financial Results
Yahoo Finance ·
Contineum Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | – | $0 | $50.0M |
| Net income | -$60.0M | -$42.3M | $22.7M |
| Diluted EPS | $-2.17 | $-2.18 | $0.08 |
| Total assets (year end) | $276.6M | $212.8M | $130.4M |
| Cash and equivalents (year end) | $75.6M | $21.9M | $15.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Contineum Therapeutics, Inc.
- Ticker
- CTNM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1855175
Frequently asked questions
What exchange is Contineum Therapeutics, Inc. listed on?
Contineum Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CTNM.
What industry is Contineum Therapeutics, Inc. in?
Contineum Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Contineum Therapeutics, Inc. headquartered?
Contineum Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Contineum Therapeutics, Inc.'s fiscal year end?
Contineum Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Contineum Therapeutics, Inc. report?
Contineum Therapeutics, Inc. reported $0 in revenue for calendar year 2024, according to its SEC filings.